147 related articles for article (PubMed ID: 28681697)
1. Analysis of Tim-3 as a therapeutic target in prostate cancer.
Piao Y; Jin X
Tumour Biol; 2017 Jul; 39(7):1010428317716628. PubMed ID: 28681697
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Tim-3 as a therapeutic target in prostate cancer.
Piao YR; Jin ZH; Yuan KC; Jin XS
Tumour Biol; 2014 Nov; 35(11):11409-14. PubMed ID: 25119597
[TBL] [Abstract][Full Text] [Related]
3. [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].
Ji P; Chen D; Bian J; Xia R; Song X; Wen W; Zhang X; Zhu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):808-11. PubMed ID: 26062425
[TBL] [Abstract][Full Text] [Related]
4. The expression of Tim-3 in peripheral blood of ovarian cancer.
Wu J; Liu C; Qian S; Hou H
DNA Cell Biol; 2013 Nov; 32(11):648-53. PubMed ID: 24007284
[TBL] [Abstract][Full Text] [Related]
5. Tim-3 on peripheral CD4⁺ and CD8⁺ T cells is involved in the development of glioma.
Han S; Feng S; Xu L; Shi W; Wang X; Wang H; Yu C; Dong T; Xu M; Liang G
DNA Cell Biol; 2014 Apr; 33(4):245-50. PubMed ID: 24512143
[TBL] [Abstract][Full Text] [Related]
6. Expression of TIM-3 on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid of rheumatoid arthritis.
Li S; Peng D; He Y; Zhang H; Sun H; Shan S; Song Y; Zhang S; Xiao H; Song H; Zhang M
APMIS; 2014 Oct; 122(10):899-904. PubMed ID: 24689929
[TBL] [Abstract][Full Text] [Related]
7. Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis.
Cheng G; Li M; Wu J; Ji M; Fang C; Shi H; Zhu D; Chen L; Zhao J; Shi L; Xu B; Zheng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9452-7. PubMed ID: 26464703
[TBL] [Abstract][Full Text] [Related]
8. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
9. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
[TBL] [Abstract][Full Text] [Related]
10. Significance of TIM-3 expression by CD4
Shariati S; Ghods A; Zohouri M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2020 Dec; 128():47-54. PubMed ID: 33068833
[TBL] [Abstract][Full Text] [Related]
11. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
Gao X; Zhu Y; Li G; Huang H; Zhang G; Wang F; Sun J; Yang Q; Zhang X; Lu B
PLoS One; 2012; 7(2):e30676. PubMed ID: 22363469
[TBL] [Abstract][Full Text] [Related]
12. Elevated Expression of T-Cell Immunoglobulin and Mucin Domain 3 on T Cells from Peripheral Blood in Patients with Cervical Carcinoma.
Li J; Sun XF; Shen Y; Yang Q; Dai SY
Gynecol Obstet Invest; 2021; 86(1-2):63-70. PubMed ID: 33279890
[TBL] [Abstract][Full Text] [Related]
13. PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis.
Qiu MK; Wang SC; Dai YX; Wang SQ; Ou JM; Quan ZW
PLoS One; 2015; 10(6):e0128523. PubMed ID: 26035207
[TBL] [Abstract][Full Text] [Related]
14. Significance of the detection of TIM-3 and FOXJ1 in prostate cancer.
Lan Y; Hu X; Jiang K; Yuan W; Zheng F; Chen H
J BUON; 2017; 22(4):1017-1021. PubMed ID: 28952222
[TBL] [Abstract][Full Text] [Related]
15. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
[TBL] [Abstract][Full Text] [Related]
16. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
[TBL] [Abstract][Full Text] [Related]
17. Blockade of Tim-3 signaling restores the virus-specific CD8⁺ T-cell response in patients with chronic hepatitis B.
Wu W; Shi Y; Li S; Zhang Y; Liu Y; Wu Y; Chen Z
Eur J Immunol; 2012 May; 42(5):1180-91. PubMed ID: 22539292
[TBL] [Abstract][Full Text] [Related]
18. An increased number of PD-1+ and Tim-3+ CD8+ T cells is involved in immune evasion in gastric cancer.
Takano S; Saito H; Ikeguchi M
Surg Today; 2016 Nov; 46(11):1341-7. PubMed ID: 26801344
[TBL] [Abstract][Full Text] [Related]
19. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of T cell immunoglobulin and mucin protein 3 in the pathogenesis of intracranial aneurysm.
Zhang HF; Zhao MG; Liang GB; Yu CY; Li ZQ; Gao X
Inflammation; 2015 Feb; 38(1):368-74. PubMed ID: 25342285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
